Idioma:

Phenylalanine and COVID-19: Tracking disease severity markers

Luporini, Rafael Luís ; Pott-Junior, Henrique ; Di Medeiros Leal, Maria Carolina B. ; Castro, Alex ; Ferreira, Antonio Gilberto ; Cominetti, Marcia Regina ; de Freitas Anibal, Fernanda

International immunopharmacology, 2021-12, Vol.101 (Pt A), p.108313-108313, Article 108313 [Periódico revisado por pares]

Netherlands: Elsevier B.V

Texto completo disponível

Citações Citado por

Enviar para

Título:
Phenylalanine and COVID-19: Tracking disease severity markers
Autor: Luporini, Rafael Luís ; Pott-Junior, Henrique ; Di Medeiros Leal, Maria Carolina B. ; Castro, Alex ; Ferreira, Antonio Gilberto ; Cominetti, Marcia Regina ; de Freitas Anibal, Fernanda
Assuntos: Adult ; Adults ; Aged ; Aged, 80 and over ; Amino acids ; Biomarkers - blood ; Comorbidity ; Coronaviruses ; COVID-19 ; COVID-19 - blood ; COVID-19 - complications ; Cross-Sectional Studies ; Cytokines ; Cytokines - blood ; Female ; Flow cytometry ; Humans ; Inflammation ; Inflammation - complications ; Inflammation - metabolism ; Interleukin 10 ; Interleukin 2 ; Interleukin 4 ; Interleukin 6 ; Linear Models ; Magnetic resonance spectroscopy ; Male ; Markers ; Metabolomics ; Middle Aged ; NMR ; NMR spectroscopy ; Nuclear magnetic resonance ; Phenylalanine ; Phenylalanine - blood ; Regression analysis ; Regression models ; SARS-CoV-2 ; Serum levels ; Severity of Illness Index ; Signs and symptoms ; Tumor necrosis factor-α ; Tyrosine ; Young Adult ; γ-Interferon
É parte de: International immunopharmacology, 2021-12, Vol.101 (Pt A), p.108313-108313, Article 108313
Notas: ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Descrição: •There is a need to investigate alternative predictors of COVID-19 severity.•Current most used markers for COVID-19 severity are not specific.•Phenylalanine and tyrosine serum levels are higher in moderate/severe COVID-19.•Phenylalanine is independently and positively associated with disease severity. Although there are several severity predictors for COVID-19, none are specific. Serum levels of phenylalanine were recently associated with increased inflammation, higher SOFA scores, ICU admission, and mortality rates among non-COVID-19 patients. Here, we investigated the relationship between phenylalanine and inflammatory markers in adults with COVID-19. We assessed adults with COVID-19 at hospital admission for clinical and laboratory data. Nuclear magnetic resonance spectroscopy measured serum levels of phenylalanine and other amino acids of its metabolomic pathway. Flow Cytometry measured serum levels of IL-2, IL-4, IL-6, Il-10, TNF-α, and IFN-γ. Linear regression models adjusted for potential confounders assessed the relationship between serum levels of phenylalanine and inflammatory cytokines. Phenylalanine and tyrosine were significantly lower in mild disease as compared to moderate and severe groups. Linear regression models showed that phenylalanine is independently and positively associated with disease severity regardless of the cytokine analyzed and after adjustment for potential confounders. In addition, mild cases showed consistently lower serum phenylalanine levels within the first ten days from disease onset to hospital admission. Phenylalanine is a marker of disease severity. This association is independent of the time between the onset of symptoms and the magnitude of the inflammatory state.
Editor: Netherlands: Elsevier B.V
Idioma: Inglês

Links

View this record in MEDLINE/PubMed

Voltar para lista de resultados

Anterior Resultado 9 Avançar Ir para próxima página

Realização: Logos de Redes Sociais:

Phenylalanine and COVID-19: Tracking disease severity markers

Luporini, Rafael Luís ; Pott-Junior, Henrique ; Di Medeiros Leal, Maria Carolina B. ; Castro, Alex ; Ferreira, Antonio Gilberto ; Cominetti, Marcia Regina ; de Freitas Anibal, Fernanda

Netherlands: Elsevier B.V

Buscando em bases de dados remotas. Favor aguardar.